Qi Lu

1.2k total citations · 1 hit paper
28 papers, 853 citations indexed

About

Qi Lu is a scholar working on Molecular Biology, Spectroscopy and Biomedical Engineering. According to data from OpenAlex, Qi Lu has authored 28 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Spectroscopy and 6 papers in Biomedical Engineering. Recurrent topics in Qi Lu's work include Glycosylation and Glycoproteins Research (6 papers), Advanced Proteomics Techniques and Applications (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Qi Lu is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Advanced Proteomics Techniques and Applications (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Qi Lu collaborates with scholars based in China, Switzerland and Macao. Qi Lu's co-authors include Guangyan Qing, Taolei Sun, Xinmiao Liang, Xiuling Li, Zhonggui He, Jin Sun, Yüting Xiong, Kaiyuan Wang, Hao Ye and Haotian Zhang and has published in prestigious journals such as Advanced Materials, Nature Communications and Biomaterials.

In The Last Decade

Qi Lu

27 papers receiving 847 citations

Hit Papers

Spatiotemporal single-cell analysis decodes cellular dyna... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi Lu China 15 472 327 179 148 139 28 853
Takeo Urakami Japan 16 468 1.0× 403 1.2× 293 1.6× 70 0.5× 173 1.2× 21 1.2k
Tingxizi Liang China 17 364 0.8× 392 1.2× 258 1.4× 75 0.5× 59 0.4× 24 866
Shey-Cherng Tzou Taiwan 15 263 0.6× 143 0.4× 100 0.6× 97 0.7× 93 0.7× 34 625
Zhihao Han China 17 470 1.0× 393 1.2× 172 1.0× 78 0.5× 34 0.2× 54 954
Sriram S. Shanmugavelandy United States 17 542 1.1× 363 1.1× 210 1.2× 94 0.6× 32 0.2× 21 1.0k
Shaolong Qi China 22 395 0.8× 289 0.9× 167 0.9× 69 0.5× 162 1.2× 60 1.1k
Huiru Lu China 20 344 0.7× 427 1.3× 256 1.4× 77 0.5× 44 0.3× 34 873
Dandan Zhu China 16 436 0.9× 99 0.3× 90 0.5× 111 0.8× 59 0.4× 44 837
Dongfan Song China 18 390 0.8× 221 0.7× 91 0.5× 353 2.4× 49 0.4× 32 910
Yuanyuan He China 17 299 0.6× 348 1.1× 137 0.8× 45 0.3× 98 0.7× 36 919

Countries citing papers authored by Qi Lu

Since Specialization
Citations

This map shows the geographic impact of Qi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Lu more than expected).

Fields of papers citing papers by Qi Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Lu. The network helps show where Qi Lu may publish in the future.

Co-authorship network of co-authors of Qi Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Lu. A scholar is included among the top collaborators of Qi Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Lu. Qi Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Qi, Xia Wang, Xiaoyuan Fan, et al.. (2025). Long-acting bioengineered platelets with internal doxorubicin loaded and external quercetin liposomes anchored for post-surgical tumor therapy. Journal of Controlled Release. 381. 113546–113546. 3 indexed citations
2.
Xiao, Ting, et al.. (2025). TPPP3, a Good Prognostic Indicator, Suppresses Cell Proliferation and Migration in OSCC. International Dental Journal. 75(2). 970–983. 1 indexed citations
4.
5.
Yang, Shengjie, et al.. (2024). Enrichment methods of N-linked glycopeptides from human serum or plasma: A mini-review. Carbohydrate Research. 538. 109094–109094. 6 indexed citations
6.
Chen, Yuqing, Dongfang Wang, Yingjie Li, et al.. (2024). Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer. Cancer Cell. 42(7). 1268–1285.e7. 62 indexed citations breakdown →
7.
Li, Lingxiao, Tian Liu, Shiyi Zuo, et al.. (2023). Satellite‐Type Sulfur Atom Distribution in Trithiocarbonate Bond‐Bridged Dimeric Prodrug Nanoassemblies: Achieving Both Stability and Activatability. Advanced Materials. 36(4). e2310633–e2310633. 29 indexed citations
8.
Wang, Kaiyuan, Xuanbo Zhang, Hao Ye, et al.. (2023). Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy. Nature Communications. 14(1). 6748–6748. 52 indexed citations
9.
Lu, Qi, Nan Lin, Xiaomeng Cheng, et al.. (2023). Maternal exposure to organophosphate flame retardants and neonatal anthropometric measures. International Journal of Hygiene and Environmental Health. 253. 114216–114216. 4 indexed citations
10.
Lyu, Wen-Yu, et al.. (2023). Identification of glycogen phosphorylase L as a potential target for lung cancer. Medical Oncology. 40(7). 211–211. 3 indexed citations
11.
Chen, Yu‐Chi, Qi Lu, Shi Wei, et al.. (2022). Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells. Biochemical Pharmacology. 197. 114940–114940. 34 indexed citations
12.
Fan, Xiaoyuan, Kaiyuan Wang, Qi Lu, et al.. (2022). Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment. Acta Biomaterialia. 154. 412–423. 24 indexed citations
13.
Zhai, Yan, et al.. (2020). MUC16 affects the biological functions of ovarian cancer cells and induces an antitumor immune response by activating dendritic cells. Annals of Translational Medicine. 8(22). 1494–1494. 21 indexed citations
14.
Wang, Kaiyuan, Hao Ye, Xuanbo Zhang, et al.. (2020). An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition. Biomaterials. 257. 120224–120224. 109 indexed citations
15.
Lu, Qi, Aihong Zhang, Yu Wang, Long Liu, & Xinghe Wang. (2019). Atom transfer radical polymer-modified paper for improvement in protein fixation in paper-based ELISA. BMC Chemistry. 13(1). 110–110. 6 indexed citations
16.
Ye, Hao, Kaiyuan Wang, Menglin Wang, et al.. (2019). Bioinspired nanoplatelets for chemo-photothermal therapy of breast cancer metastasis inhibition. Biomaterials. 206. 1–12. 141 indexed citations
18.
Qing, Guangyan, Qi Lu, Xiuling Li, et al.. (2017). Hydrogen bond based smart polymer for highly selective and tunable capture of multiply phosphorylated peptides. Nature Communications. 8(1). 461–461. 80 indexed citations
19.
Qing, Guangyan, Qi Lu, Yüting Xiong, et al.. (2017). New Opportunities and Challenges of Smart Polymers in Post‐Translational Modification Proteomics. Advanced Materials. 29(20). 73 indexed citations
20.
Lu, Qi, et al.. (2017). Developing an Inositol-Phosphate-Actuated Nanochannel System by Mimicking Biological Calcium Ion Channels. ACS Applied Materials & Interfaces. 9(38). 32554–32564. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026